232 related articles for article (PubMed ID: 15731405)
1. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice.
Sakatani T; Kaneda A; Iacobuzio-Donahue CA; Carter MG; de Boom Witzel S; Okano H; Ko MS; Ohlsson R; Longo DL; Feinberg AP
Science; 2005 Mar; 307(5717):1976-8. PubMed ID: 15731405
[TBL] [Abstract][Full Text] [Related]
2. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer.
Nakagawa H; Chadwick RB; Peltomaki P; Plass C; Nakamura Y; de La Chapelle A
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):591-6. PubMed ID: 11120891
[TBL] [Abstract][Full Text] [Related]
3. Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate.
Fu VX; Dobosy JR; Desotelle JA; Almassi N; Ewald JA; Srinivasan R; Berres M; Svaren J; Weindruch R; Jarrard DF
Cancer Res; 2008 Aug; 68(16):6797-802. PubMed ID: 18701505
[TBL] [Abstract][Full Text] [Related]
4. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
[TBL] [Abstract][Full Text] [Related]
5. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
Cui H; Onyango P; Brandenburg S; Wu Y; Hsieh CL; Feinberg AP
Cancer Res; 2002 Nov; 62(22):6442-6. PubMed ID: 12438232
[TBL] [Abstract][Full Text] [Related]
6. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice.
Hassan AB; Howell JA
Cancer Res; 2000 Feb; 60(4):1070-6. PubMed ID: 10706126
[TBL] [Abstract][Full Text] [Related]
8. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability.
Cui H; Horon IL; Ohlsson R; Hamilton SR; Feinberg AP
Nat Med; 1998 Nov; 4(11):1276-80. PubMed ID: 9809551
[TBL] [Abstract][Full Text] [Related]
9. Loss of
Damaschke NA; Yang B; Bhusari S; Avilla M; Zhong W; Blute ML; Huang W; Jarrard DF
Cancer Res; 2017 Oct; 77(19):5236-5247. PubMed ID: 28775169
[TBL] [Abstract][Full Text] [Related]
10. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.
Li T; Vu TH; Ulaner GA; Littman E; Ling JQ; Chen HL; Hu JF; Behr B; Giudice L; Hoffman AR
Mol Hum Reprod; 2005 Sep; 11(9):631-40. PubMed ID: 16219628
[TBL] [Abstract][Full Text] [Related]
11. Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk.
Kaneda A; Wang CJ; Cheong R; Timp W; Onyango P; Wen B; Iacobuzio-Donahue CA; Ohlsson R; Andraos R; Pearson MA; Sharov AA; Longo DL; Ko MS; Levchenko A; Feinberg AP
Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20926-31. PubMed ID: 18087038
[TBL] [Abstract][Full Text] [Related]
12. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk.
Kaneda A; Feinberg AP
Cancer Res; 2005 Dec; 65(24):11236-40. PubMed ID: 16357124
[TBL] [Abstract][Full Text] [Related]
13. Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting.
Harper J; Burns JL; Foulstone EJ; Pignatelli M; Zaina S; Hassan AB
Cancer Res; 2006 Feb; 66(4):1940-8. PubMed ID: 16488992
[TBL] [Abstract][Full Text] [Related]
14. A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate.
Dobosy JR; Fu VX; Desotelle JA; Srinivasan R; Kenowski ML; Almassi N; Weindruch R; Svaren J; Jarrard DF
Prostate; 2008 Aug; 68(11):1187-95. PubMed ID: 18459101
[TBL] [Abstract][Full Text] [Related]
15. Examination of IGF2 and H19 loss of imprinting in bladder cancer.
Byun HM; Wong HL; Birnstein EA; Wolff EM; Liang G; Yang AS
Cancer Res; 2007 Nov; 67(22):10753-8. PubMed ID: 18006818
[TBL] [Abstract][Full Text] [Related]
16. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.
Ulaner GA; Yang Y; Hu JF; Li T; Vu TH; Hoffman AR
Endocrinology; 2003 Oct; 144(10):4420-6. PubMed ID: 12960026
[TBL] [Abstract][Full Text] [Related]
17. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk.
Cui H; Cruz-Correa M; Giardiello FM; Hutcheon DF; Kafonek DR; Brandenburg S; Wu Y; He X; Powe NR; Feinberg AP
Science; 2003 Mar; 299(5613):1753-5. PubMed ID: 12637750
[TBL] [Abstract][Full Text] [Related]
18. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
Yballe CM; Vu TH; Hoffman AR
J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
[TBL] [Abstract][Full Text] [Related]
19. A genetic approach to cancer epigenetics.
Feinberg AP
Cold Spring Harb Symp Quant Biol; 2005; 70():335-41. PubMed ID: 16869770
[TBL] [Abstract][Full Text] [Related]
20. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
Wu J; Qin Y; Li B; He WZ; Sun ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
